1. Sampson CB, Hesslewood SR. Altered biodistribution of radiopharmaceuticals as a result of pharmacological or chemical interaction. In: Theobald AE, ed.Radiopharmaceuticals and radiopharmacy practice. London: Taylor and Francis; 1989:132?151.
2. Sampson CB. Drugs and chemicals which affect the purity, biodistribution and pharmacokinetics of radiopharmaceuticals.J Biopharm Sci 1990;1(4):381?400.
3. Lentle BC, Scott JR. Iatrogenic alterations in radionuclide biodistribution.Semin Nucl Med 1979;9:131?143.
4. Hladik WB, Nigg NK, Rhodes BA. Drug induced changes in the biologic distribution of radiopharmaceuticals.Semin Nucl Med 1982;12:184?218.
5. Hladik WB, Ponto JA, Lentle BC, Laven DL. Iatrogenic alterations in the biodistribution of radiotracers as a result of drug therapy: reported instances. In: Hladik WB, Saha BG, Study KT, eds.Essentials of nuclear medicine science. New York: Williams and Wilkins;1987:189?219.